Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21977534 | 0.77 | — | — | |
| SCHEMBL21977491 | 0.75 | — | — | |
| SCHEMBL21977498 | 0.74 | TTR (0.32) | TTR | |
| SCHEMBL21977521 | 0.74 | TTR (0.32) | TTR | |
| SCHEMBL21977477 | 0.70 | — | — | |
| SCHEMBL21977520 | 0.69 | — | — | |
| SCHEMBL1629107 | 0.67 | TTR (0.43) | TTR | |
| SCHEMBL9861537 | 0.67 | TTR (0.43) | TTR | |
| SCHEMBL1628524 | 0.67 | TTR (0.43) | TTR | |
| SCHEMBL1629140 | 0.67 | TTR (0.43) | TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11312734-B2 | Nitrogen-containing cyclic organoxysilane compound and method for producing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-04-26 | — | — | US | disclosed |
| EP-3660025-B1 | NITROGEN-CONTAINING CYCLIC ORGANOXYSILANE COMPOUND AND METHOD FOR PRODUCING THE SAME | SHINETSU CHEMICAL CO (JP) | 2022-03-23 | — | — | EP | disclosed |
| EP-3660025-A1 | NITROGEN-CONTAINING CYCLIC ORGANOXYSILANE COMPOUND AND METHOD FOR PRODUCING THE SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2020-06-03 | — | — | EP | disclosed |
| CN-111217849-A | Nitrogen-containing cyclic organooxysilane compound and method for producing same | 信越化学工业株式会社 | 2020-06-02 | — | — | CN | disclosed |
| US-20200165276-A1 | NITROGEN-CONTAINING CYCLIC ORGANOXYSILANE COMPOUND AND METHOD FOR PRODUCING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11312734-B2 | Nitrogen-containing cyclic organoxysilane compound and method for producing the same | OR10J3, HRH3, HRH4 | TTR 1578/4885 |
| US-20200165276-A1 | NITROGEN-CONTAINING CYCLIC ORGANOXYSILANE COMPOUND AND METHOD FOR PRODUCING THE SAME | OR10J3, HRH3, HRH4 | TTR 1578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.